- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 233/94 - Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to other ring members
Patent holdings for IPC class C07D 233/94
Total number of patents in this class: 34
10-year publication summary
|
2
|
1
|
2
|
2
|
8
|
4
|
2
|
1
|
2
|
3
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Evofem Biosciences, Inc. | 47 |
14 |
| Galderma Research & Development | 404 |
3 |
| Theaprin Pharmaceuticals Inc. | 35 |
2 |
| Sanofi | 4077 |
2 |
| Merck Patent GmbH | 5812 |
1 |
| The Johns Hopkins University | 5679 |
1 |
| Auckland UniServices Limited | 493 |
1 |
| China Pharmaceutical University | 301 |
1 |
| Fudan University | 689 |
1 |
| National University Corporation Hokkaido University | 1344 |
1 |
| Nihon Medi-physics Co., Ltd. | 179 |
1 |
| Symbiomix Therapeutics, LLC | 3 |
1 |
| Technische Universitat Munchen | 690 |
1 |
| Lupin Inc. | 66 |
1 |
| Zhejiang Yangshengtang Institute of Natural Medication Co., Ltd. | 51 |
1 |
| Merck Sharp & Dohme LLC | 3749 |
1 |
| Anpel Laboratory Technologies (Shanghai) Inc. | 8 |
1 |
| Other owners | 0 |